
UHS Stock Forecast & Price Target
UHS Analyst Ratings
Bulls say
Universal Health Services has demonstrated strong financial growth, with its acute care segment achieving a same-store sales revenue increase of 12.8% and an adjusted EBITDA margin expansion of 190 basis points to 15.8%. The behavioral health segment has shown resilience and growth potential, with same-store revenue rising by 9.3% and improved patient volumes, indicating a positive trend for future performance. Additionally, anticipated CMS program approvals could yield an estimated benefit of $75-80 million, further enhancing the company’s financial outlook as it effectively manages costs and capacity expansions.
Bears say
Universal Health Services is facing a negative outlook due to anticipated volume and margin headwinds, which are expected to lead to earnings approximately 5% below earlier estimates for FY26, with an enterprise multiple projected at around 5.5x, reflecting trough levels seen in 2024. The company's behavioral health volumes are projected to trend at just 2% in 2026, following an adjustment in its long-term outlook, and significant concerns remain regarding the decline of the DPP contribution to EBITDA, which is expected to impact earnings by $420-470 million over the 2028-2032 period. Additional risks include concentration in the Las Vegas market, potential regulatory changes affecting healthcare policies, and a tightening labor supply that could further pressure productivity and margins in urban areas.
This aggregate rating is based on analysts' research of Universal Health Services and is not a guaranteed prediction by Public.com or investment advice.
UHS Analyst Forecast & Price Prediction
Start investing in UHS
Order type
Buy in
Order amount
Est. shares
0 shares